Copyright Reports & Markets. All rights reserved.

Global Influenza A Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Influenza A Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Intramuscular Vaccine
    • 1.3.3 Nasal Spray Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Influenza A Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 3-18 Years Old
    • 1.4.3 Above 18 Years Old
  • 1.5 Global Influenza A Vaccine Market Size & Forecast
    • 1.5.1 Global Influenza A Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Influenza A Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Influenza A Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Influenza A Vaccine Product and Services
    • 2.1.4 Novartis Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Influenza A Vaccine Product and Services
    • 2.2.4 Sanofi Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Influenza A Vaccine Product and Services
    • 2.3.4 GSK Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Medimmune
    • 2.4.1 Medimmune Details
    • 2.4.2 Medimmune Major Business
    • 2.4.3 Medimmune Influenza A Vaccine Product and Services
    • 2.4.4 Medimmune Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Medimmune Recent Developments/Updates
  • 2.5 Abbott
    • 2.5.1 Abbott Details
    • 2.5.2 Abbott Major Business
    • 2.5.3 Abbott Influenza A Vaccine Product and Services
    • 2.5.4 Abbott Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abbott Recent Developments/Updates
  • 2.6 Mitsubishi Tanabe Pharma
    • 2.6.1 Mitsubishi Tanabe Pharma Details
    • 2.6.2 Mitsubishi Tanabe Pharma Major Business
    • 2.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
    • 2.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck Influenza A Vaccine Product and Services
    • 2.7.4 Merck Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck Recent Developments/Updates
  • 2.8 Sinovac Biotech
    • 2.8.1 Sinovac Biotech Details
    • 2.8.2 Sinovac Biotech Major Business
    • 2.8.3 Sinovac Biotech Influenza A Vaccine Product and Services
    • 2.8.4 Sinovac Biotech Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sinovac Biotech Recent Developments/Updates
  • 2.9 Hualan Biological Engineering
    • 2.9.1 Hualan Biological Engineering Details
    • 2.9.2 Hualan Biological Engineering Major Business
    • 2.9.3 Hualan Biological Engineering Influenza A Vaccine Product and Services
    • 2.9.4 Hualan Biological Engineering Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hualan Biological Engineering Recent Developments/Updates
  • 2.10 Changsheng Bio-Technology
    • 2.10.1 Changsheng Bio-Technology Details
    • 2.10.2 Changsheng Bio-Technology Major Business
    • 2.10.3 Changsheng Bio-Technology Influenza A Vaccine Product and Services
    • 2.10.4 Changsheng Bio-Technology Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Changsheng Bio-Technology Recent Developments/Updates
  • 2.11 Beijing Tiantan Bio-Products
    • 2.11.1 Beijing Tiantan Bio-Products Details
    • 2.11.2 Beijing Tiantan Bio-Products Major Business
    • 2.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
    • 2.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates

3 Competitive Environment: Influenza A Vaccine by Manufacturer

  • 3.1 Global Influenza A Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Influenza A Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Influenza A Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Influenza A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Influenza A Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Influenza A Vaccine Manufacturer Market Share in 2025
  • 3.5 Influenza A Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Influenza A Vaccine Market: Region Footprint
    • 3.5.2 Influenza A Vaccine Market: Company Product Type Footprint
    • 3.5.3 Influenza A Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Influenza A Vaccine Market Size by Region
    • 4.1.1 Global Influenza A Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Influenza A Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Influenza A Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Influenza A Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Influenza A Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Influenza A Vaccine Consumption Value (2021-2032)
  • 4.5 South America Influenza A Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Influenza A Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Influenza A Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Influenza A Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Influenza A Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Influenza A Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Influenza A Vaccine Market Size by Country
    • 7.3.1 North America Influenza A Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Influenza A Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Influenza A Vaccine Market Size by Country
    • 8.3.1 Europe Influenza A Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Influenza A Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Influenza A Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Influenza A Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Influenza A Vaccine Market Size by Country
    • 10.3.1 South America Influenza A Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Influenza A Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Influenza A Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Influenza A Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Influenza A Vaccine Market Drivers
  • 12.2 Influenza A Vaccine Market Restraints
  • 12.3 Influenza A Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Influenza A Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Influenza A Vaccine
  • 13.3 Influenza A Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Influenza A Vaccine Typical Distributors
  • 14.3 Influenza A Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Influenza A Vaccine market size was valued at US$ 8833 million in 2025 and is forecast to a readjusted size of US$ 13350 million by 2032 with a CAGR of 6.2% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Influenza A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Influenza A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Influenza A Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Influenza A Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech, Hualan Biological Engineering, Changsheng Bio-Technology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Influenza A Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Intramuscular Vaccine
    Nasal Spray Vaccine
    Market segment by Application
    3-18 Years Old
    Above 18 Years Old
    Major players covered
    Novartis
    Sanofi
    GSK
    Medimmune
    Abbott
    Mitsubishi Tanabe Pharma
    Merck
    Sinovac Biotech
    Hualan Biological Engineering
    Changsheng Bio-Technology
    Beijing Tiantan Bio-Products
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Influenza A Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Influenza A Vaccine, with price, sales quantity, revenue, and global market share of Influenza A Vaccine from 2021 to 2026.
    Chapter 3, the Influenza A Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Influenza A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Influenza A Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza A Vaccine.
    Chapter 14 and 15, to describe Influenza A Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now